Delivery Order SPE2DB20D1100-SPE2DB24FC3H6

Award Date 6/18/24
Potential Completion Date 6/20/24
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of NUCYNTA 50 MG TABLET 100S to the Defense Logistics Agency (DLA), a defense agency. The $1,793.79 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 20, 2024. The award appears to be under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of NUCYNTA 50 MG TABLET 100S. The contract, valued at $1,755.36, was awarded by the Defense Logistics Agency (DLA) on June 11, 2024, with a completion date of June 12, 2024. The contract is a Delivery Order under the firm fixed price pricing type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award is for the delivery of NUCYNTA 50 MG TABLET 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $1,314.54 and an ultimate completion date of December 16, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This is a Delivery Order contract with a Firm Fixed Price pricing type. The contract is not designated with a set-aside....
This federal contract award is for the delivery of NUCYNTA ER 100 MG TABLET 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $3,402.39. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 20, 2025. The contract is not designated as a Set-Aside. Amerisourcebergen...
This federal contract award is for the delivery of NUCYNTA 100 MG TABLET 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The award was made to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order with a ceiling value of $6,199.72 and a performance period through March 27, 2024. Amerisourcebergen Drug Corp...
This federal contract award is for the supply of the pharmaceutical product NUCYNTA ER 100 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order with a Firm Fixed Price of $1,388.98 and a completion date of June 18, 2024. The contract does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,702.32 firm-fixed-price delivery order is for the supply of NUCYNTA 75 MG tablets. The contract has an ultimate completion date of March 5, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a $5,592.00 firm fixed-price delivery order for the supply of 4565132195 NUCYNTA 100 MG TABLET 100S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation. Amerisourcebergen, one of the largest pharmaceutical distribution companies, has a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,417.34 firm fixed-price delivery order is for the supply of NUCYNTA 50 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of January 23, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $1,225.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order awarded under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of NUCYNTA 50 MG TABLET 100S, a pharmaceutical product, to support military...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC3H6
    Delivery Order

This federal contract award is for the delivery of NUCYNTA 50 MG TABLET 100S, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for $3,467.76. This delivery order contract has a firm fixed price and an ultimate completion date of June 20, 2024.

Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract was awarded on a full and open competition basis without any set-aside designation.

Generated 9/17/24, 9:15 AM